Stockreport

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

INmune Bio Inc. - Common stock  (INMB) 
PDF Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentat [Read more]